Effective Treatment of Low Risk Acute Gvhd with Itacitinib Monotherapy
Capellini A, Etra A, Alousi AM, Al Malki MM, Choe H, Defilipp Z, Hogan WJ, Kitko CL, Ayuk FA, Baez J, Gandhi I, Kasikis S, Gleich S, Hexner EO, Hoepting M, Kapoor U, Kowalyk S, Kwon D, Langston A, Mielcarek M, Morales G, Ozbek U, Qayed M, Reshef R, Rösler W, Spyrou N, Young R, Chen YB, Ferrara JLM, Levine JE (2022)
Publication Type: Conference contribution
Publication year: 2022
Journal
Publisher: AMER SOC HEMATOLOGY
City/Town: WASHINGTON
Pages Range: 1867-1869
Conference Proceedings Title: BLOOD
Event location: New Orleans, LA
DOI: 10.1182/blood-2022-156000
Authors with CRIS profile
Involved external institutions
Icahn School of Medicine at Mount Sinai
United States (USA) (US)
Universität Regensburg
Germany (DE)
Mayo Clinic
United States (USA) (US)
Fred Hutchinson Cancer Research Center
United States (USA) (US)
Vanderbilt University
United States (USA) (US)
Emory University
United States (USA) (US)
Universitätsklinikum Hamburg-Eppendorf (UKE)
Germany (DE)
University of Pennsylvania
United States (USA) (US)
Massachusetts General Hospital
United States (USA) (US)
Columbia University
United States (USA) (US)
Ohio State University
United States (USA) (US)
City of Hope Medical Center
United States (USA) (US)
University of Texas MD Anderson Cancer Center
United States (USA) (US)
United States (USA) (US)
Universität Regensburg
Germany (DE)
Mayo Clinic
United States (USA) (US)
Fred Hutchinson Cancer Research Center
United States (USA) (US)
Vanderbilt University
United States (USA) (US)
Emory University
United States (USA) (US)
Universitätsklinikum Hamburg-Eppendorf (UKE)
Germany (DE)
University of Pennsylvania
United States (USA) (US)
Massachusetts General Hospital
United States (USA) (US)
Columbia University
United States (USA) (US)
Ohio State University
United States (USA) (US)
City of Hope Medical Center
United States (USA) (US)
University of Texas MD Anderson Cancer Center
United States (USA) (US)
How to cite
APA:
Capellini, A., Etra, A., Alousi, A.M., Al Malki, M.M., Choe, H., Defilipp, Z.,... Levine, J.E. (2022). Effective Treatment of Low Risk Acute Gvhd with Itacitinib Monotherapy. In BLOOD (pp. 1867-1869). New Orleans, LA: WASHINGTON: AMER SOC HEMATOLOGY.
MLA:
Capellini, Alexandra, et al. "Effective Treatment of Low Risk Acute Gvhd with Itacitinib Monotherapy." Proceedings of the 64th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH), New Orleans, LA WASHINGTON: AMER SOC HEMATOLOGY, 2022. 1867-1869.
BibTeX: Download